Answers are grounded in this paper and cite their sources.
The renewed interest in ultra‐low‐field MRI (< 0.1 T), with its advantages of cost‐effectiveness and portability, is expected to drive a paradigm shift from traditional MRI scanners to point‐of‐care imaging systems. Here, we characterized the in vivo T 1 and T 2 relaxation times of healthy breast tissues using quantitative MRI at 50 mT to advance the development of ultra‐low‐field breast MRI methodologies. First, the developed in vivo quantitative mapping protocols were tested and validated using CuSO 4 ‐doped water phantom experiments on the custom‐built 50‐mT MRI prototype. Then, in vivo quantitative T 1 and T 2 mapping of human breast tissues was measured in healthy female subjects. The T 1 and T 2 values for fat tissue, fibrous tissue, and glandular tissue components were determined using an automatic segmentation method based on the relaxation times. The mean T 1 times were 121.21 ± 14.57, 182.26 ± 20.96, and 238.32 ± 10.71 ms for fat tissue, fibrous tissue, and glandular tissue, respectively. While the mean T 2 times were 111.36 ± 14.28 and 69.44 ± 15.26 ms for fat tissue and fibroglandular tissue, respectively. For healthy breast tissues, the significantly shorter T 1 times at 50 mT are favorable for improving the imaging speed. T 2 times are similar to those seen at conventional clinical field strengths. Additionally, the relatively small difference in T 2 times between fibrous tissue and glandular tissue made it difficult to segment these two tissues independently. This work can provide a valuable reference for future breast tissues diagnostic imaging in ultra‐low‐field MRI scenarios, thereby promoting the wider adoption of portable breast MRI in routine breast disease screening.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: